2002
DOI: 10.1016/s0303-7207(01)00670-0
|View full text |Cite
|
Sign up to set email alerts
|

1,25-Dihydroxyvitamin D3 selectively translocates PKCα to nuclei in ROS 17/2.8 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
8
1

Year Published

2003
2003
2010
2010

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 37 publications
0
8
1
Order By: Relevance
“…PKCα is another kinase that has been shown to be activated rapidly by 1,25(OH) 2 D treatment in a variety of cell types [Balogh et al, 2000; Capiati et al, 2000; Rivera-Bermudez et al, 2002; Boyan et al, 2003; Schwartz et al, 2003; Wali et al, 2003]. In contrast to these reports showing rapid activation of PKCα by 1,25(OH) 2 D, our study did not show this effect in prostate epithelial progenitor cells.…”
Section: Discussioncontrasting
confidence: 99%
See 3 more Smart Citations
“…PKCα is another kinase that has been shown to be activated rapidly by 1,25(OH) 2 D treatment in a variety of cell types [Balogh et al, 2000; Capiati et al, 2000; Rivera-Bermudez et al, 2002; Boyan et al, 2003; Schwartz et al, 2003; Wali et al, 2003]. In contrast to these reports showing rapid activation of PKCα by 1,25(OH) 2 D, our study did not show this effect in prostate epithelial progenitor cells.…”
Section: Discussioncontrasting
confidence: 99%
“…The nVDR plays a critical role in mediating ligand-induced transcriptional regulation of a variety of genes that are important for cell proliferation, differentiation, and apoptosis. In addition, several kinases have been shown to be rapidly regulated by 1,25(OH) 2 D, including extracellular-regulated kinase (ERK) 1/2 [Beno et al, 1995; Marcinkowska et al, 1997; Song et al, 1998; Chen et al, 1999; Morelli et al, 2001; Buitrago et al, 2001a,b; Galbiati et al, 2002; Schwartz et al, 2002; Johansen et al, 2003; Capiati et al, 2004; Pardo and de Boland, 2004] and protein kinase C α (PKCα) [Balogh et al, 2000; Capiati et al, 2000; Rivera-Bermudez et al, 2002; Boyan et al, 2003; Schwartz et al, 2003; Wali et al, 2003], which may contribute to the regulation of genes that are not direct targets of nVDR [Farach-Carson and Davis, 2003]. However, the mechanisms mediating growth inhibition by vitamin D that lead to prostate cancer prevention, as well as therapy by vitamin D analogues, are not known definitively.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…In addition to the nuclear receptors, many studies have demonstrated the effects of 1,25(OH) 2 D 3 on PKC isoforms in a number of different cell lines including rat osteoblasts [van Leeuwen et al, 1992;Boyan et al, 2002;Rivera-Bermudez et al, 2002]. It is not clear how 1,25(OH) 2 D 3 regulates PKC activity in these cells.…”
mentioning
confidence: 99%